USD/CAD Falls Slightly After Reaching Multi-Year High What Caused the Decline? The USD/CAD pair recently hit a multi-year high of 1.4245 on Friday but has since dipped to around 1.4230 during Asian trading hours on Monday. This drop can be attributed to the weakened US Dollar against the Canadian Dollar, influenced by lackluster US Treasury…
Kinnevik’s Top Holdings in the Healthcare and Software Sectors Kinnevik’s top five holdings in the healthcare and software sectors continue to demonstrate strong growth, though they remain unprofitable. During the recent Investor Day, management highlighted the growth opportunities for these companies while also sharing their medium-term outlook and strategic priorities. Based on my conservative valuation,…
Welcome to the Future of Education with Bright Scholar Bright Scholar Education Holdings Limited The world of education is constantly evolving, and Bright Scholar Education Holdings Limited is at the forefront of this evolution. With a global reach and a commitment to providing premier education services, Bright Scholar is shaping the future of learning. An…
Altimmune 2025: Revolutionizing Obesity and MASH Treatment – A Humorous and Quirky Take Description: Altimmune is making waves in the medical field by venturing into the realms of obesity and MASH treatment with their innovative GLP-1/Glucagon dual-agonist drug, Pemvidutide. This groundbreaking drug offers targeted weight loss in fat cells and muscle protection, all while maintaining…
Welcome to the Future of Biopharmaceuticals As we move into a new era of medical advancements, the field of biopharmaceuticals continues to push the boundaries of what is possible. On December 16, 2024, Inventiva, a leading clinical-stage biopharmaceutical company based in Daix, France and New York City, announced a major development in their quest to…
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU Patients Results Expected to Promote Awareness and Adoption of PKU GOLIKE GENEVA, SWITZERLAND / ACCESSWIRE / December 16, 2024 RELIEF THERAPEUTICS Holding SA (SIX:RLF )(OTCQB:RLFTF )(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet…
Charmingly Eccentric: Exploring the TPLC ETF What is TPLC? TPLC is a large/mid-cap core ETF designed to offer broad exposure to stocks passing proprietary Biblically Responsible Investing criteria. With fees at 0.52% and $272 million in assets, this fund aims to provide high-quality exposure to less volatile stocks. However, its weighting scheme may work against…
Roadzen Inc. Announces Pricing of Public Offering in 2024: Get Ready to Invest! NEW YORK, Dec. 15, 2024 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN), (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced the pricing of an underwritten public offering of 2,000,000 ordinary shares (or…
